Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-071965

Chief Financial Officer gave up 9,346 shares (to pay taxes)

  • Chief Financial Officer acquired 18,850 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bellemin Jean-Marc Chief Financial Officer 2022-06-14 Option exercise +18,850 18,850 D: show line 1 in the form
Bellemin Jean-Marc Chief Financial Officer 2022-06-14 Shares withheld for taxes −9,346 $7.73 $72,245 9,504 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bellemin Jean-Marc Chief Financial Officer 2022-06-14 Grant or award · Restricted Stock Units +18,850 18,850 D: show line 3 in the form
Loading xslF345X03/tm2218629-2_4seq1.xml…